Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Pharmaceutical Administration and Regulations in Japan - Nihs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Approval of Manufactur<strong>in</strong>g/Market<strong>in</strong>g of<br />
Medic<strong>in</strong>al Products” (partially revised by<br />
Office Communication on April 22, 2005 <strong>and</strong><br />
on non-prescription drugs partially revised by<br />
Notification No. 1020002 of the Evaluation<br />
<strong>and</strong> Licens<strong>in</strong>g Division, PFSB dated October<br />
20, 2008).<br />
Subsequently, an agreement was reached<br />
on the Common Technical Document (CTD)<br />
by the ICH (International Conference on<br />
Harmonization of Technical Requirements for<br />
Registration of <strong>Pharmaceutical</strong>s for Human<br />
Use) <strong>and</strong> a notification entitled “H<strong>and</strong>l<strong>in</strong>g<br />
Data Attached to Drug Approval Applications”<br />
(Notification No. 663 of the PMSB, MHLW<br />
dated June 21, 2001), which is a partial<br />
revision of the previous notification<br />
mentioned above. On the same day,<br />
another notification entitled the “Guidel<strong>in</strong>es<br />
for Preparation of Data Attached to<br />
Applications for Approval to Manufacture or<br />
Import New Drugs” (Notification No. 899 of<br />
the Evaluation <strong>and</strong> Licens<strong>in</strong>g Division,<br />
PMSB, dated June 21, 2001, partially revised<br />
by Notification No. 0701004 of the Evaluation<br />
<strong>and</strong> Licens<strong>in</strong>g Division, PFSB, dated July 1,<br />
2003, Notification No. 0525003 of the<br />
Evaluation <strong>and</strong> Licens<strong>in</strong>g Division, PFSB<br />
dated May 25, 2004, Office Communication<br />
dated May 24, 2004, <strong>and</strong> Notification No.<br />
0707-(3) of the Evaluation <strong>and</strong> Licens<strong>in</strong>g<br />
Division, PFSB dated July 7, 2009) was<br />
issued to specify guidel<strong>in</strong>es for preparation of<br />
<strong>Pharmaceutical</strong> <strong>Regulations</strong> <strong>in</strong> <strong>Japan</strong>:<br />
data to be attached to approval applications<br />
based on the CTD. The data required for<br />
approval applications us<strong>in</strong>g CTD format is<br />
shown below. The data <strong>in</strong> Modules 2 to 5<br />
are prepared on the basis of the CTD<br />
guidel<strong>in</strong>es shown <strong>in</strong> Attachments 1 <strong>and</strong> 3 to 5<br />
of these guidel<strong>in</strong>es.<br />
For electronic specifications of the CTD<br />
(e-CTD), “Electronic Specifications of the<br />
Common Technical Document” (Notification<br />
No. 06404001 of the PFSB dated June 4,<br />
2003, partially revised by Notifications No.<br />
0527001 of the Evaluation <strong>and</strong> Licens<strong>in</strong>g<br />
Division, PFSB dated May 27, 2004, No.<br />
0527004, 0825001, <strong>and</strong> 0707-(3) dated<br />
August 25, 2008, <strong>and</strong> July 7, 2009,<br />
respectively). These specifications were<br />
enforced from October 1, 2008. H<strong>and</strong>l<strong>in</strong>g of<br />
submissions of electronic data <strong>and</strong> Q&A are<br />
shown <strong>in</strong> the H<strong>and</strong>l<strong>in</strong>g of Electronic<br />
Specifications for Common Technical<br />
Documents (Notification No. 0527004 of the<br />
Evaluation <strong>and</strong> Licens<strong>in</strong>g Division, PMSB<br />
dated May 27, 2004, partially revised by<br />
Notification No. 0707-(3) of the Evaluation<br />
<strong>and</strong> Licens<strong>in</strong>g Division, PMSB dated July 7,<br />
2009), Office Communications dated March<br />
31, 2005, April 27, 2005, October 5, 2006,<br />
December 22, 2006, July 7, 2009, <strong>and</strong><br />
February 26, 2010. In <strong>Japan</strong>, submission of<br />
eCTD is not obligatory but it is<br />
recommended. It is no longer necessary to<br />
submit paper data for approval applications if<br />
2011-3 - 68 -